We are live on ! Find out more
Alkeon Capital Management

Alkeon Capital Management Portfolio holdings

AUM $59.5B
1-Year Est. Return 51.63%
This Fund
S&P 500
This Quarter Est. Return
+4.7%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$54B
AUM Growth
-$5.26B
Cap. Flow
-$7.55B
Cap. Flow %
-13.98%
Top 10 Hldgs %
49.89%
Holding
190
New
14
Increased
43
Reduced
46
Closed
38

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$849M
2
BABA icon
Alibaba
BABA
+$551M
3
DLO icon
dLocal
DLO
+$178M
4
BIDU icon
Baidu
BIDU
+$156M
5
NTES icon
NetEase
NTES
+$155M

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$311M
2
ATVI
Activision Blizzard
ATVI
+$246M
3
SNPS icon
Synopsys
SNPS
+$242M
4
XLRN
Acceleron Pharma
XLRN
+$214M
5
TWLO icon
Twilio
TWLO
+$214M

Sector Composition

Rank Sector Weight
1 Technology 26.2%
2 Consumer Discretionary 10.52%
3 Financials 4.99%
4 Communication Services 4.7%
5 Real Estate 2.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRBU icon
126
Caribou Biosciences
CRBU
$164M
$18.8M 0.03%
1,246,625
CRWD icon
127
CrowdStrike
CRWD
$218B
$15.4M 0.03%
300,000
+180,000
+150% +$11M
STEM icon
128
Stem
STEM
$52.7M
$15.2M 0.03%
40,000
+12,500
+45% +$5.42M
ZM icon
129
Zoom
ZM
$30.6B
$14M 0.03%
76,000
-80,000
-51% -$18.8M
KPTI icon
130
Karyopharm Therapeutics
KPTI
$48M
$12.6M 0.02%
130,773
WGS icon
131
GeneDx Holdings
WGS
$2.3B
$11.4M 0.02%
77,530
+7,575
+11% +$1.69M
DDOG icon
132
Datadog
DDOG
$84B
$10.5M 0.02%
58,915
KLRS
133
Kalaris Therapeutics
KLRS
$96.8M
$9.91M 0.02%
33,305
-14,239
-30% -$6.61M
YSG
134
Yatsen Holding
YSG
$319M
$9.01M 0.02%
837,938
+310,000
+59% +$4.34M
SONY icon
135
Sony
SONY
$138B
$6.95M 0.01%
275,000
TAL icon
136
TAL Education Group
TAL
$6.87B
$5.89M 0.01%
+1,500,000
New +$6.78M
MREO
137
Mereo BioPharma
MREO
$47.3M
$3.1M 0.01%
1,935,600
MDB icon
138
MongoDB
MDB
$32.1B
$2.47M ﹤0.01%
+4,673
New +$2.39M
COST icon
139
Costco
COST
$420B
$1.54M ﹤0.01%
2,722
NGNE icon
140
Neurogene
NGNE
$712M
$1.08M ﹤0.01%
11,247
-13,753
-55% -$1.68M
AAL icon
141
CALL
American Airlines Group
AAL
$10.6B
-6,500,000
Closed -$133M
ADSK icon
142
Autodesk
ADSK
$52.6B
-605,198
Closed -$173M
ALEC icon
143
Alector
ALEC
$199M
-60,000
Closed -$1.37M
ALNY icon
144
Alnylam Pharmaceuticals
ALNY
$29.3B
-390,551
Closed -$73.7M
AMD icon
145
CALL
Advanced Micro Devices
AMD
$789B
-1,540,000
Closed -$158M
APLT
146
DELISTED
Applied Therapeutics
APLT
-639,458
Closed -$10.6M
CCL icon
147
CALL
Carnival Corporation Ltd
CCL
$39.7B
-2,016,800
Closed -$50.4M
DLB icon
148
Dolby
DLB
$5.79B
-175,000
Closed -$15.4M
DOCU
149
CALL
DocuSign
DOCU
$11.5B
-1,000,000
Closed -$257M
DOCU
150
DocuSign
DOCU
$11.5B
-149,321
Closed -$38.4M

Similar funds

Alkeon Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Alkeon Capital Management held 190 positions worth $54B, down 8.9% from $59.2B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Alkeon Capital Management withdrew a net $7.55B in Q4 2021, closing 38 positions and reducing 46 holdings. Its most notable exit was Netflix, an estimated $311M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Alkeon Capital Management opened a new position in Qualcomm worth $970M.

  • Alkeon Capital Management's largest Q4 2021 buy was Qualcomm: 5,305,000 shares worth $970M.
  • Alkeon Capital Management added most to Alibaba in Q4 2021, an estimated $551M increase.
  • Alkeon Capital Management's biggest Q4 2021 reduction was Activision Blizzard, cutting an estimated $246M.
  • Alkeon Capital Management fully exited Netflix in Q4 2021, selling an estimated $311M.
  • Alkeon Capital Management's ten largest holdings make up 50% of its $54B portfolio in Q4 2021.
  • Alkeon Capital Management opened 14 new positions and closed 38 in Q4 2021.
  • Alkeon Capital Management's portfolio value fell 8.9% quarter-over-quarter to $54B.

Based on Alkeon Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.